Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01082926
Brief Title: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

First Submitted : March 5, 2010
First Submitted that Met QC Criteria : March 8, 2010
First Posted : March 9, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : June 3, 2015
Last Update Posted : June 8, 2015 (Estimate)